An edition of Granting additional market exclusivity to the drug Ansaid (1992)
Granting additional market exclusivity to the drug Ansaid
hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 20, 1992.
By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health and the Environment.
0 (0 Ratings)
0 Want to read0 Currently reading0 Have read
0 Want to read0 Currently reading0 Have read
Publish Date
1992
Publisher
U.S. G.P.O.,For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Language
eng
Pages
66
Description:
subjects: Flurbiprofen, Patent extensions, Pharmaceutical policy, Upjohn Company
Places: United States